Analyst Ratings For Envision Healthcare (NYSE:EVHC)
Today, Credit Suisse Group raised its price target on Envision Healthcare (NYSE:EVHC) to $43.50 per share.
Some recent analyst ratings include
- 1/10/2018-Stephens Reiterated Rating of Hold.
- 1/5/2018-Cantor Fitzgerald Reiterated Rating of Hold.
- 12/13/2017-Piper Jaffray Companies initiated coverage with a Neutral rating.
- On 7/3/2017 Robert Jon Coward, Insider, sold 1,500 with an average share price of $62.69 per share and the total transaction amounting to $94,035.00.
- On 6/22/2017 Robert Jon Coward, Insider, sold 1,500 with an average share price of $60.00 per share and the total transaction amounting to $90,000.00.
- On 5/3/2017 Robert Jon Coward, Insider, sold 1,500 with an average share price of $60.53 per share and the total transaction amounting to $90,795.00.
- On 4/3/2017 Robert Jon Coward, Insider, sold 1,500 with an average share price of $61.34 per share and the total transaction amounting to $92,010.00.
- On 3/10/2017 John Thomas Gawaluck, Director, bought 1,500 with an average share price of $66.65 per share and the total transaction amounting to $99,975.00.
- On 3/1/2017 Robert Jon Coward, Insider, sold 1,500 with an average share price of $65.00 per share and the total transaction amounting to $97,500.00.
- On 10/5/2015 Leonard M Riggs Jr, Director, sold 4,000 with an average share price of $36.24 per share and the total transaction amounting to $144,960.00.
Recent Trading Activity for Envision Healthcare (NYSE:EVHC)
Shares of Envision Healthcare closed the previous trading session at 35.77 down -0.47 1.30% with 592180 shares trading hands.